Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apixaban, Warfarin, and Aspirin for PVT prevention after splenectomy
NCT04645550Phase 4Completed
- Sponsor
- Subei People's Hospital
- Start
- Nov 2020
- Primary completion
- Dec 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in portal vein thrombosis (PVT) comparing Apixaban with dipyridamole, Warfarin with dipyridamole and Aspirin with dipyridamole (3 arms). Primary endpoint: Proportion of patients with portal vein thrombosis or spleno-mesenteric thrombosis at 2 years. Started Nov 2020; status: completed.
02
Drugs
apixabanwarfarinaspirin
03
Conditions
portal vein thrombosis (PVT)
Beyond the preview
Go deeper on NCT04645550.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04645550.